---
$id: https://graph.org.ai/products/commodity/51314201
$type: Product
source: UNSPSC
code: "51314201"
title: "Hypostamine or tritoqualine"
class: "51314200"
classTitle: "Antihistamine or H1 blocker tropanes"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hypostamine or tritoqualine

**UNSPSC Code**: 51314201
**Class**: [Antihistamine or H1 blocker tropanes](Antihistamine or H1 blocker tropanes.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholagogue, choleretic, histamine h1 antagonist, and phthalic anhydride with the molecular formula C26H32N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F4MW5166YH, chemically known as 4,5,6-triethoxy-7-amino-3-(8-methoxy-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydro-1-isochinolinyl)phthalid but generally known as tritoqualine, which bears US NIH Compound Identifier 72145. European Medicines Agency schedules Tritoqualine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11326MIG. World Health Organization schedules tritoqualine in its Anatomical Therapeutic Chemical (ATC) Classification. TRITOQUALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Hypostamine or tritoqualine bears US NLM identifiers UMLS ID C0077316 and NCI Concept Code C97409. SMILES: O1C(C2N(CCC3C2C(OC)C2OCOC2C3)C)C2C(C1=O)C(N)C(OCC)C(OCC)C2OCC.

